Search Tag: valsartan
2022 27 Aug
The latest findings from the PERSPECTIVE trial were presented at the ESC Congress in Barcelona. The study aimed to evaluate sacubitril/valsartan compared with valsartan among symptomatic heart failure patients. The study included 592 patients with symptomatic heart failure. Two hundred and ninety-five patients received 97/103 mg sacubitril/valsartan,...Read more
2021 27 Aug
At the ESC Congress 2021 today, latest insights into the progression to, and management of, heart failure were presented. Dr Carolyn Ho of Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA, discussed the results of the VANISH (Valsartan for Attenuating Disease Evolution in Early Sarcomeric HCM) trial. This trial...Read more
2019 09 Jan
The Food and Drug Administration (FDA) has been recalling several blood pressure medications that contain valsartan. The drug is commonly prescribed to patients with hypertension. The recent recalls have been due to concerns regarding the presence of N-nitrosodimethylamine (NDEA), a carcinogenic element that could cause cancer in patients who...Read more